Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Dexmedetomidine vs Esketamine for Pediatric Preoperative Sedation
NCT07050212Recruiting
- Sponsor
- Maternal and Child Health Hospital of Hubei Province
- Start
- Apr 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam in preoperative anxiety (3 arms), sponsored by Maternal and Child Health Hospital of Hubei Province. Primary endpoints: Sedation success rate at 10 months, Onset time of sedation at 10 months and 1 more. Started Apr 2025; status: recruiting.
02
Drugs
remimazolam
03
Conditions
preoperative anxiety
Beyond the preview
Go deeper on NCT07050212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07050212.